Minshan Chen

10.6k citations

190 papers · 5.1k indexed · 2 hit papers · h-index 35

Impact in

Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
Cancer Research top 2%
- Cancer, Lipids, and Metabolism

Papers in ⓘ

Hepatology 143
- Hepatocellular Carcinoma Treatment and Prognosis 139
Cancer Research 46
- Cancer, Lipids, and Metabolism 31

Co-authors: Yaojun Zhang (103 shared papers)Li Xu (61 shared papers)Masatoshi Kudo (7 shared papers)Rong Guo (25 shared papers)Lucinda Orsini (3 shared papers)Philip J. Johnson (2 shared papers)Myron Schwartz (2 shared papers)Morris Sherman (2 shared papers)
Journals: Journal of Clinical Oncology (11 papers)International Journal of Surgery (10 papers)Hepatology (5 papers)Frontiers in Pharmacology (5 papers)Frontiers in Oncology (5 papers)
Partner nations: China United States Hong Kong

In The Last Decade

Minshan Chen

185 papers receiving 5.0k citations

Hit Papers

align trajectories log scale

TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study 2023 · 71 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 International Journal of Surgery
2015 Liver International

Peers

Countries citing papers authored by Minshan Chen

Since Specialization

Citations

This map shows the geographic impact of Minshan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minshan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minshan Chen more than expected).

Fields of papers citing papers by Minshan Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minshan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minshan Chen. The network helps show where Minshan Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Minshan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Minshan Chen Line = papers co-authored together Minshan Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 190 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study Liver International ·Joong‐Won Park, Minshan Chen, M. Colombo, Lewis R. Roberts, Myron Schwartz, Pei‐Jer Chen, Masatoshi Kudo, Philip J. Johnson, Samuel Wagner, Lucinda Orsini, Morris Sherman Hit paper breakdown →	2015	879
2	A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial–mesenchymal transition–independent manner Hepatology ·Jian‐Hong Fang, Huichao Zhou, Chong Zhang, Li‐Ru Shang, Lei Zhang, Jing Xu, Limin Zheng, Yunfei Yuan, Rong Guo, Wei‐Hua Jia, Jing‐Ping Yun, Minshan Chen, Yaojun Zhang, Shi‐Mei Zhuang	2015	186
3	IMbrave 050: A Phase III Trial of Atezolizumab Plus Bevacizumab in High-Risk Hepatocellular Carcinoma after Curative Resection or Ablation Future Oncology ·Stephen P. Hack, Jessica Spahn, Minshan Chen, Ann‐Lii Cheng, Ahmed O. Kaseb, Masatoshi Kudo, Han Chu Lee, Adam C. Yopp, Pierce K. H. Chow, Shukui Qin	2020	151
4	Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy versus lenvatinib alone for advanced hepatocellular carcinoma Therapeutic Advances in Medical Oncology ·Minke He, Run-Bin Liang, Yang Zhao, Yu-Jie Xu, Huanwei Chen, Yuan-Min Zhou, ZhiCheng Lai, Li Xu, Wei Wei, Yaojun Zhang, Minshan Chen, Rong Guo, QiJiong Li, Ming Shi	2021	138
5	Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis Journal of Clinical Investigation ·Chong Wu, Huiheng Ning, Mingyu Liu, Jie Lin, Shufeng Luo, Wenjie Zhu, Xu Jing, Wen-Chao Wu, Jing Liang, Chun‐Kui Shao, Jiaqi Ren, Bin Wei, Jun Cui, Minshan Chen, Limin Zheng	2018	122
6	Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety Cancer Communications ·Wei Wei, Pei‐En Jian, Shaohua Li, Zhi‐Xing Guo, Yong‐Fa Zhang, Yihong Ling, Xiaojun Lin, Li Xu, Ming Shi, Lie Zheng, Minshan Chen, Rong Guo	2018	119
7	Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition) Liver Cancer ·Shuqun Cheng, Minshan Chen, Jianqiang Cai, Juxian Sun, Rong Guo, Xinyu Bi, Wan Yee Lau, Mengchao Wu	2019	114
8	Postoperative Neutrophil-to-Lymphocyte Ratio Change Predicts Survival of Patients with Small Hepatocellular Carcinoma Undergoing Radiofrequency Ablation PLoS ONE ·Jiaqiang Dan, Yaojun Zhang, Zhenwei Peng, Junting Huang, Hengjun Gao, Li Xu, Minshan Chen	2013	104
9	Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery Biomaterials ·Ruei‐Min Lu, Yu‐Ling Chang, Minshan Chen, Han‐Chung Wu	2011	102
10	An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus Hepatology ·Xiuping Zhang, Yuzhen Gao, Zhenhua Chen, Minshan Chen, Le‐Qun Li, Tian‐Fu Wen, Li Xu, Kang Wang, Zong‐Tao Chai, Wei‐Xing Guo, Jie Shi, Dong Xie, Mengchao Wu, Wan Yee Lau, Shuqun Cheng	2018	95
11	Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Predictor of Sorafenib Benefit in Patients with Hepatocellular Carcinoma Hepatology ·Jian‐Hong Fang, Li Xu, Li‐Ru Shang, C. Pan, Jin Ding, Yunqiang Tang, Hui Liu, Chu‐Xing Liu, Jia‐Lin Zheng, Yaojun Zhang, Zhongguo Zhou, Jing Xu, Limin Zheng, Minshan Chen, Shi‐Mei Zhuang	2018	92
12	Serum copper and zinc levels at diagnosis and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort International Journal of Cancer ·Aiping Fang, Peiyan Chen, Xiaoyan Wang, Zhao‐Yan Liu, Daoming Zhang, Yun Luo, Gong‐Cheng Liao, Jing‐An Long, Rong‐Huan Zhong, Zhongguo Zhou, Yanjun Xu, Xiaojun Xu, Wenhua Ling, Minshan Chen, Yaojun Zhang, Huilian Zhu	2018	82
13	Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging PLoS ONE ·Ruei‐Min Lu, Minshan Chen, De-Kuan Chang, Chien‐Yu Chiu, Wei-Chuan Lin, Shin-Long Yan, Yi‐Ping Wang, Yuan‐Sung Kuo, Chen-Yun Yeh, Albert Lo, Han‐Chung Wu	2013	73
14	TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study International Journal of Surgery ·Yichuan Yuan, Wei He, Zhiwen Yang, Jiliang Qiu, Zhenkun Huang, Yunxing Shi, Lin Zhu, Yun Zheng, Minshan Chen, Wan Yee Lau, Binkui Li, Yunfei Yuan Hit paper breakdown →	2023	71
15	The Effects of Anesthetic Technique on Cancer Recurrence in Percutaneous Radiofrequency Ablation of Small Hepatocellular Carcinoma Anesthesia & Analgesia ·Renchun Lai, Zhenwei Peng, Dongtai Chen, Xudong Wang, Wei Xing, Weian Zeng, Minshan Chen	2011	68
16	Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR Oncotarget ·Yuanliang Wang, Anne-Marie C. Overstreet, Minshan Chen, Jiang Wang, Huajun Zhao, Po-Chun Ho, Molly A. Smith, Shao‐Chun Wang	2015	66
17	Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma Liver International ·Xiang‐Ming Lao, Guangyu Luo, Liang‐Tao Ye, Cheng Luo, Ming Shi, Dian Wang, Rong Guo, Minshan Chen, Shengping Li, Xiaojun Lin, Yunfei Yuan	2013	65
18	Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation Radiology ·Zhenwei Peng, Shuling Chen, Mengchao Wei, Manxia Lin, Chunlin Jiang, Jie Mei, Bin Li, Yu Wang, Jiaping Li, Xiaoyan Xie, Minshan Chen, Guojun Qian, Ming Kuang	2018	61
19	Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition Oncotarget ·Shuqun Cheng, Minshan Chen, Jianqiang Cai	2016	56
20	Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients BMC Cancer ·Xuqi Sun, Jie Mei, Wen‐Ping Lin, Ziliang Yang, Wei Peng, Jinbin Chen, Yaojun Zhang, Li Xu, Minshan Chen	2021	55

About Minshan Chen

Minshan Chen is a scholar working on Hepatology, Cancer Research, Oncology, Pathology and Forensic Medicine and Epidemiology, having authored 190 papers that have together received 5.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (139 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (58 papers), Liver Disease Diagnosis and Treatment (39 papers), Cancer, Lipids, and Metabolism (31 papers), Cancer Mechanisms and Therapy (30 papers), Hepatitis B Virus Studies (25 papers), Inflammatory Biomarkers in Disease Prognosis (14 papers) and Cancer Immunotherapy and Biomarkers (13 papers). The work is most often cited by research in Hepatology (3.1k citations), Cancer Research (1.0k citations), Oncology (1.3k citations), Pathology and Forensic Medicine (772 citations) and Epidemiology (1.4k citations). Minshan Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yaojun Zhang, Li Xu, Masatoshi Kudo, Rong Guo, Lucinda Orsini, Philip J. Johnson, Myron Schwartz, Morris Sherman, Lewis R. Roberts and Pei‐Jer Chen. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Surgery, Hepatology, Frontiers in Pharmacology and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact